Participants |
40 participants with MCI randomly allocated to NBCT. |
5 participants with MCI randomly allocated to HomeCoRe. |
10 participants with MCI randomly allocated to SMRT. |
55 MCI, randomly assigned to one of three control groups (CG): CG for NBCT (n = 40), CG for HomeCoRe (n = 5), CG for SMRT (n = 10). |
Interventions |
Cognitive training specifically designed to promote cognitive functions in early stages of neurodegenerative conditions. |
Cognitive training specifically designed to promote cognitive functions in early stages of neurodegenerative conditions. |
Cognitive training specifically designed to promote cognitive functions in early stages of neurodegenerative conditions. |
This activity is commonly used as a control condition to test the efficacy of innovative rehabilitative treatments. |
Outcome measures |
Primary outcome: Assessment of resting-state functional connectivity at baseline (T0) and at the end of NBCT (T1 after 4 weeks). Secondary outcome: Global cognitive and neuropsychological changes at T1, T2, and T3 vs. T0 when applicable according to Table 1. Secondary outcome measures will also include participant-centered assessment at T1. |
Primary outcome: Assessment of resting-state functional connectivity at baseline (T0) and at the end of HomeCoRe (T1 after 6 weeks). Secondary outcome: Global cognitive and neuropsychological changes at T1, T2, and T3 vs. T0 when applicable according to Table 1. Secondary outcome measures will also include participant-centered assessment at T1. |
Primary outcome: Assessment of resting-state functional connectivity at baseline (T0) and at the end of SMRT (T1 after 6 weeks). Secondary outcome: Global cognitive and neuropsychological changes at T1, T2, and T3 vs. T0 when applicable according to Table 1. Secondary outcome measures will also include participant-centered assessment at T1. |
Primary outcome: Assessment of resting-state functional connectivity at baseline (T0) and at the end of sham intervention (T1 after 4 or 6 weeks). Secondary outcome: Global cognitive and neuropsychological changes at T1, T2, and T3 vs. T0 when applicable according to Table 1. Secondary outcome measures will also include participant-centered assessment at T1. |